Curis (CRIS) Non Operating Income (2010 - 2026)
Curis (CRIS) reported Non Operating Income of -$12.7 million for Q1 2026, down 2662.53% on a YoY basis from $494824.0 in Q1 2025, and down 4721.29% quarter-over-quarter from -$263000.0 in Q4 2025.
Curis (CRIS) Non Operating Income (2010 - 2026) Analysis & Trends
Curis has reported Non Operating Income for 17 years, with the latest figure at -$12.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 2662.53% year-over-year to -$12.7 million; the trailing twelve-month figure through Mar 2026 stood at -$14.1 million (down 14050.5% YoY), and the FY2025 full-year result was -$1.9 million, down 262.1% from the prior year.
- Non Operating Income for Q1 2026 stood at -$12.7 million, down from -$263000.0 in the prior quarter.
- The five-year high for Non Operating Income was $709000.0 in Q2 2024, with the low at -$12.7 million in Q1 2026.
- Historically, Non Operating Income has averaged -$948764.7 across 5 years, with a median of -$342000.0 in 2025.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 772.06% — and 2026, when it slumped 2662.53%.
- Curis' Non Operating Income stood at -$1.1 million in 2022, then surged by 143.91% to $487000.0 in 2023, then tumbled by 228.13% to -$624000.0 in 2024, then jumped by 57.85% to -$263000.0 in 2025, then plunged by 4721.29% to -$12.7 million in 2026.
- The last three Non Operating Income figures came in at -$12.7 million (Q1 2026), -$263000.0 (Q4 2025), and -$805000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -12.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.68 Mn |
| Dec 31, 2025 | -263,000.00 |
| Sep 30, 2025 | -805,000.00 |
| Jun 30, 2025 | -342,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Dec 31, 2024 | -624,000.00 |
| Sep 30, 2024 | 475,000.00 |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 593,000.00 |
| Dec 31, 2023 | 487,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 177,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | -1.11 Mn |
| Sep 30, 2022 | -688,000.00 |
| Jun 30, 2022 | -879,000.00 |
| Mar 31, 2022 | -976,000.00 |
| Dec 31, 2021 | -4.26 Mn |
| Sep 30, 2021 | -1.00 Mn |
| Jun 30, 2021 | 2.02 Mn |